However, all 5 breast carcinomas with HER-2 data failed to show amplification, which is in line with that expected for BRCA1 but is not considered in the multi-likelihood model, where it could have compensated the odds calculated for receptors. This evidence concerns the gene BRCA1 and breast carcinoma.